Pharmacokinetics and safety of panobacumab: specific adjunctive immunotherapy in critical patients with nosocomial Pseudomonas aeruginosa O11 pneumonia.
Lu Q, Rouby JJ, Laterre PF, Eggimann P, Dugard A, Giamarellos-Bourboulis EJ, Mercier E, Garbino J, Luyt CE, Chastre J, Georgescu-Kyburz V, Rudolf MP, Gafner V, Lazar H, Koch H, Perez A, Krämer SD, Tamm M.
Lu Q, et al. Among authors: chastre j.
J Antimicrob Chemother. 2011 May;66(5):1110-6. doi: 10.1093/jac/dkr046. Epub 2011 Mar 10.
J Antimicrob Chemother. 2011.
PMID: 21398296
Clinical Trial.